CTLA4 and glioblastoma: Gene expression analysis of in-house glioblastoma samples confirmed that HAVCR2 expression was higher than other well-known immune checkpoint inhibitors such as CTLA4, PD-1, PD-L1, PD-L2, and IDO1.